ARCHIVES

Blueprint Group co-chairman Mark Ratain says group seeks “the perfect peer review system,” but a member’s email questions the proposal.

This article is from The Cancer Letter archive.

Vol. 30 No. 33 | August 13, 2004

Download PDF Visit The Full Archive

Related Articles

Niederhuber: Clinical Trials System Must Refocus To Emphasize Translational Studies.

July 9, 2010

Cancer Control Awards $1 .5 Million Grant For 3-Year Study By College Of Radiology

April 26, 1974

Cedars-Sinai Develops Criteria For FDG-PET In Breast Cancer

August 25, 2006

Funding Opportunities: NIH Creates Awards For Clinical Research

March 27, 1998

Also in this 8-page issue: Amgen names PhRMA executive Rodger Currie vice president for government affairs.

April 30, 2004

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996